TrendFlares logo

Inhibrx, Inc. (INBX)

$17.43 6.22% $1.02 Healthcare

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

$252.32M

Mr. Mark Paul Lappe

106.00

La Jolla, CA

Aug 19, 2020

0.15

$118.84

3.51

3.82

5.96%

-15,207.80%

-2.87

-0.03

67.20

110.46

3.56

-93.96%

-678.51%

Downtrend

Similar stocks (14)

Crinetics Pharmaceuticals, Inc.

CRNX

$53.94 0.26%
Uptrend

Protagonist Therapeutics, Inc.

PTGX

$46.20 -1.74%
Uptrend

Viridian Therapeutics, Inc.

VRDN

$21.56 -2.27%
Neutral

Stoke Therapeutics, Inc.

STOK

$14.72 1.73%
Neutral

Celcuity Inc.

CELC

$15.14 1.07%
Downtrend

Eliem Therapeutics, Inc.

ELYM

$8.24 -2.60%
Uptrend

Larimar Therapeutics, Inc.

LRMR

$6.69 -7.08%
Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$5.62 -7.57%
Neutral

Lyell Immunopharma, Inc.

LYEL

$1.24 0.81%
Downtrend

Design Therapeutics, Inc.

DSGN

$5.55 0.18%
Uptrend

Werewolf Therapeutics, Inc.

HOWL

$2.14 -8.55%
Downtrend

Ikena Oncology, Inc.

IKNA

$1.72 1.78%
Uptrend

Kronos Bio, Inc.

KRON

$0.95 0.20%
Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00%
Downtrend

ETF Exposure (24)

iShares Micro-Cap ETF

IWC

0.04555%

$122.64 -0.28%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$202.06 0.06%
Neutral

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$88.01 0.39%
Neutral

iShares Russell 2000 Growth ETF

IWO

0.00796%

$277.57 0.12%
Uptrend

iShares Russell 2000 ETF

IWM

0.00654%

$217.67 0.39%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00536%

$165.82 0.59%
Uptrend

ProShares Ultra Russell2000

UWM

0.002486783621471849%

$41.65 0.77%
Neutral

ProShares UltraPro Russell2000

URTY

0.0012271820680792168%

$49.88 1.11%
Neutral

ProShares Hedge Replication ETF

HDG

0.0010365971350971281%

$49.80 0.13%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

2.5e-4%

$123.28 0.22%
Uptrend

iShares Russell 3000 ETF

IWV

2.2e-4%

$320.56 0.23%
Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$69.46 -0.46%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.45 0.51%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.44 0.51%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.44 0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.10 0.71%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.07 0.71%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.94 0.72%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$249.12 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$277.72 0.18%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.92 0.72%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0%

$146.07 0.43%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$178.36 0.55%
Uptrend